{"id":"https://genegraph.clinicalgenome.org/r/f6b5403a-09ad-495a-8e46-7199ef687321v1.0","type":"EvidenceStrengthAssertion","dc:description":"NECAP1 was first reported in relation to autosomal recessive developmental and epileptic encephalopathy in 2014 (Alazami et al., PMID 24399846). This condition is characterized by onset of seizures before 3 months of age, global developmental delay, and hypotonia. At least 3 variants (e.g. missense, splice, and nonsense) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level, segregation, and experimental data. Summary of Case Level Data: 6.2 points. Variants in this gene have been reported in at least 5 probands in 6 publications (PMIDs: 24399846, 30202406, 30525121, 30626896, 32552793, 35638367). Notably, four of these publications report individuals from Saudi Arabia with the same p.R48* founder variant. The GCEP capped the curation weight provided by this variant at 6 points to avoid over-interpreting its importance (this includes 3 points for variant interpretation and 3 points for segregation). Variants in this gene segregated with disease in 5 additional affected family members. The mechanism for disease appears to be homozygous loss of function (PMID: 24399846, 30626896). This gene-disease association is also supported by biochemical function and protein interaction studies. NECAP1 has a role in Clathrin-mediated endocytosis, is essential to synaptic vesicle recycling, and which directly controls neuronal excitability (PMID: 35115907). While the biochemical role of NECAP1 is supportive of a role in seizures, it was not considered to be specific enough evidence to count towards clinical validity for the gene. The protein encoded by NECAP1 binds AP2 (PMID: 31430451) which is encoded by AP2M1 and is associated with seizures (PMID: 31104773). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Epilepsy GCI on the meeting date January 17, 2023 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/f6b5403a-09ad-495a-8e46-7199ef687321","GCISnapshot":"https://genegraph.clinicalgenome.org/r/8fa4d835-8c26-4b30-9f26-7b6fb64d6a0b","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/8fa4d835-8c26-4b30-9f26-7b6fb64d6a0b_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2023-01-17T20:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/8fa4d835-8c26-4b30-9f26-7b6fb64d6a0b_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2023-01-23T19:38:45.191Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8fa4d835-8c26-4b30-9f26-7b6fb64d6a0b_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/733b0af2-2d5e-412a-88df-b7b86158b47f_proband_score_evidence_line","type":"EvidenceLine","direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d1dfaf5c-ba44-449d-b40f-40a84b62dca7","type":"EvidenceLine","dc:description":"This variant appears to be a founder mutation in the Saudi Arabian population, so we will not score this individual separately from the family scored in Alazami et al. 2014 (PMID: 24399846).","calculatedScore":3.0,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d1dfaf5c-ba44-449d-b40f-40a84b62dca7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30525121","allele":{"id":"https://genegraph.clinicalgenome.org/r/056846d4-b4cb-42b2-81b6-a99af1e49da6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015509.4(NECAP1):c.142C>T (p.Arg48Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA210886"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/733b0af2-2d5e-412a-88df-b7b86158b47f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30525121","rdfs:label":"30525121_Family_IV:3","allele":{"id":"https://genegraph.clinicalgenome.org/r/056846d4-b4cb-42b2-81b6-a99af1e49da6"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0011968","obo:HP_0001250","obo:HP_0012444","obo:HP_0001508","obo:HP_0001252","obo:HP_0012758","obo:HP_0001347"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d1dfaf5c-ba44-449d-b40f-40a84b62dca7_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/f944e3a9-7429-46e3-ab61-ddaf2a301b61_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b5ad40f-7030-4fb1-8a96-df714f02f9e3","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b5ad40f-7030-4fb1-8a96-df714f02f9e3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35638367","allele":{"id":"https://genegraph.clinicalgenome.org/r/3ee8924e-8f42-4474-8195-710c16882dc0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015509.4(NECAP1):c.22G>A (p.Glu8Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA383795341"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/f944e3a9-7429-46e3-ab61-ddaf2a301b61","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35638367","rdfs:label":"35638367_proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/3ee8924e-8f42-4474-8195-710c16882dc0"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000252","obo:HP_0012758","obo:HP_0001252","obo:HP_0001250"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/9b5ad40f-7030-4fb1-8a96-df714f02f9e3_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/c2b3203f-916d-43d7-a92d-a3ea86d41cb8_proband_score_evidence_line","type":"EvidenceLine","direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/764816c7-ec0f-4223-9ee5-d01094a96211","type":"EvidenceLine","dc:description":"This subject was not scored for two reasons: 1. manuscript provided insufficient phenotypic details to determine the proband's disease, and 2. this variant appears to be a founder mutation in the Saudi Arabian population and was already scored in Alazami et al. 2014,PMID: 24399846.\n","calculatedScore":3.0,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/764816c7-ec0f-4223-9ee5-d01094a96211_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32552793","allele":{"id":"https://genegraph.clinicalgenome.org/r/056846d4-b4cb-42b2-81b6-a99af1e49da6"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/c2b3203f-916d-43d7-a92d-a3ea86d41cb8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32552793","rdfs:label":"32552793_08DG00213","allele":{"id":"https://genegraph.clinicalgenome.org/r/056846d4-b4cb-42b2-81b6-a99af1e49da6"},"detectionMethod":"Exome followed by RNAseq","firstTestingMethod":"Exome sequencing","secondTestingMethod":"Other","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/764816c7-ec0f-4223-9ee5-d01094a96211_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/dd4fc717-4379-48c3-9580-d9e5d6b25068_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b8b79cd2-fad8-4541-8ebc-be265fa73882","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b8b79cd2-fad8-4541-8ebc-be265fa73882_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24399846","allele":{"id":"https://genegraph.clinicalgenome.org/r/056846d4-b4cb-42b2-81b6-a99af1e49da6"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/dd4fc717-4379-48c3-9580-d9e5d6b25068","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24399846","rdfs:label":"24399846_Family_V:3","allele":{"id":"https://genegraph.clinicalgenome.org/r/056846d4-b4cb-42b2-81b6-a99af1e49da6"},"detectionMethod":"Homozygosity mapping revealed a single autozygous interval and targeted exome sequencing revlealed only one homozygous variant within the interval.","firstTestingMethod":"Homozygosity mapping","secondTestingMethod":"Exome sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/b8b79cd2-fad8-4541-8ebc-be265fa73882_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/b63a4d7d-5b6e-49b9-abc6-aaf58a0fe8d5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2cfee36b-eab9-43e0-973a-7aacb98598af","type":"EvidenceLine","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2cfee36b-eab9-43e0-973a-7aacb98598af_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant is subject to nonsense-mediated decay, confirmed in patient-derived\nlymphoblast cells.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2cfee36b-eab9-43e0-973a-7aacb98598af_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30626896","allele":{"id":"https://genegraph.clinicalgenome.org/r/e9283fbe-0756-47b2-ab8a-8c0f38eb94aa","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015509.4(NECAP1):c.301+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA383797946"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/b63a4d7d-5b6e-49b9-abc6-aaf58a0fe8d5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30626896","rdfs:label":"30626896_Proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/e9283fbe-0756-47b2-ab8a-8c0f38eb94aa"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001250","obo:HP_0001252","obo:HP_0012758"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/2cfee36b-eab9-43e0-973a-7aacb98598af_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/8fa4d835-8c26-4b30-9f26-7b6fb64d6a0b_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a682e097-b333-46c8-a59f-93c065ec26ff_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24399846","rdfs:label":"24399846_FAm","estimatedLodScore":3.76,"family":{"id":"https://genegraph.clinicalgenome.org/r/a682e097-b333-46c8-a59f-93c065ec26ff","type":"Family","rdfs:label":"24399846_FAm","member":{"id":"https://genegraph.clinicalgenome.org/r/dd4fc717-4379-48c3-9580-d9e5d6b25068"}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":6,"phenotypePositiveAllelePositive":6,"phenotypes":["obo:HP_0012758","obo:HP_0012444","obo:HP_0001252","obo:HP_0011968","obo:HP_0001250"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/dd4fc717-4379-48c3-9580-d9e5d6b25068"},"publishedLodScore":5,"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":9.2},{"id":"https://genegraph.clinicalgenome.org/r/8fa4d835-8c26-4b30-9f26-7b6fb64d6a0b_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8fa4d835-8c26-4b30-9f26-7b6fb64d6a0b_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3113ce37-c2da-4cf0-acab-aca252130ad3","type":"EvidenceLine","dc:description":"The GCEP decided that this biochemical function is not specific enough to support a role in epilepsy","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6c8365ed-58e6-4a11-a7ba-65f0c6221285","type":"Finding","dc:description":"Clathrin-mediated endocytosis is essential to synaptic vesicle recycling, which directly controls neuronal excitability.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24399846","rdfs:label":"Vesicle Size Increased and Number Decreased in Knockdown","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/8997157c-fccf-4650-a8aa-1a61d07f0533","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3818bebd-c55f-4ff4-aced-62d7957408c1","type":"Finding","dc:description":"AP2M1 Impairs Clathrin-Mediated Endocytosis and Causes Developmental and Epileptic Encephalopathy, PMID: 31104773","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24399846","rdfs:label":"AP2 co-immunoprecipitates with NECAP1","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0.5}],"evidenceStrength":"Moderate","sequence":5811,"specifiedBy":"GeneValidityCriteria9","strengthScore":9.7,"subject":{"id":"https://genegraph.clinicalgenome.org/r/RnIm-QZlHlU","type":"GeneValidityProposition","disease":"obo:MONDO_0100062","gene":"hgnc:24539","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_8fa4d835-8c26-4b30-9f26-7b6fb64d6a0b-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}